tyrosine and Brain Ischemia

tyrosine has been researched along with Brain Ischemia in 132 studies

Research

Studies (132)

TimeframeStudies, this research(%)All Research%
pre-19901 (0.76)18.7374
1990's12 (9.09)18.2507
2000's61 (46.21)29.6817
2010's55 (41.67)24.3611
2020's3 (2.27)2.80

Authors

AuthorsStudies
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Bae, EJ; Hwang, JY; Kang, HM; Kim, S; Kim, YJ; Park, C; Park, KS; Song, MY1
Afonso, C; Bonino, L; Borthagaray, G; López, E; Medeiros, R; Pitt, A; Rossi, S; Sousa, B; Spickett, C1
Baud, O; Bonnin, P; Charriaut-Marlangue, C; Eloi, M; Leger, PL; Pansiot, J; Paven, E; Renolleau, S1
Abdelsaid, M; Ergul, A; Fagan, SC; Hafez, S1
Che, R; Chen, J; Duan, J; Feng, W; Ji, X; Li, C; Liebeskind, D; Ling, F; Shang, S; Song, H; Wang, Y; Wu, C; Wu, L; Zhang, H; Zhao, W1
Feng, W; Huang, SH; Li, W; Li, XS; Liang, CR; Lin, L; Liu, CC; Wang, H; Wang, YJ; Wu, Y; Xu, ZQ; Zhang, LL; Zhang, M1
Duan, Y; Fang, Y; Gao, L; Huang, Y; Li, J; Luo, Y; Shi, W; Sun, Y; Zhao, H; Zhao, Y1
Arumugam, TV; Broughton, BR; Chu, HX; Drummond, GR; Evans, MA; Gelderblom, M; Huber, S; Kim, HA; Lee, S; Magnus, T; Piepke, M; Sakkal, S; Shim, R; Sobey, CG; Vinh, A; Wong, CH; Zhang, SR1
Li, P; Li, Y; Wang, S; Wei, J; Yang, Q1
Bae, HJ; Chung, JW; Han, MK; Jang, MS; Jung, C; Kim, JH; Kim, KJ; Kwon, OK; Lee, J; Lee, JS; Noh, WY; Oh, CW; Yang, MH1
Aass, HC; Amthor, KF; Ormstad, H; Sandvik, L; Verkerk, R1
Cheng, Y; Fu, Y; Han, J; Liang, H; Sun, L; Xu, Y; Yang, L1
Bukowski, MJ; Hüttemann, M; Ji, Q; Kumar, R; Lee, I; Mahapatra, G; Pecina, P; Salomon, AR; Sanderson, TH; Sinkler, C; Tousignant, RN; Varughese, A; Yu, K1
Abraha, I; Ciccone, A; Cozzolino, F; Motto, C; Santilli, I1
Wei, D; Xiong, X; Zhao, H1
Baik, SK; Hwang, YH; Kang, DH; Kim, YS; Kim, YW; Park, SP1
Takagi, N1
Chen, JH; Kuo, HC; Lee, KF; Tsai, TH1
Chen, CC; Chen, JH; Chen, WP; Hsieh, MC; Huang, WS; Kuo, HC; Lee, KC; Lee, KF; Lee, LY; Lu, CC; Shen, CH; Teng, CC1
Du, CP; Hou, XY; Kong, FS; Li, T; Liu, Y; Sun, CC; Wang, Y; Xu, H; Zhu, QJ1
Castañeda-Arellano, R; Feria-Velasco, AI; Rivera-Cervantes, MC1
Ji, X; Li, J; Liu, P; Luo, Y; Tao, Z; Wang, R; Yan, F; Zhang, C; Zhao, H1
Deng, J; Xiong, L; Zuo, Z1
Alameda, F; Bosch-Morató, M; Caballo, C; Escolar, G; Galan, AM; Gil-Gómez, G; Guivernau, B; Guix, FX; Ill-Raga, G; Jiménez-Conde, J; Lopez-Vilchez, I; Muñoz, FJ; Ois, A; Opazo, C; Palomer, E; Pérez-Asensio, F; Planas, AM; Ramos-Fernández, E; Reyes-Navarro, M; Roquer, J; Tajes, M; Valls-Comamala, V; Valverde, MA1
Barry, DM; Dai, XR; Fan, ML; Hou, SX; Jin, H; Kong, F; Lau, LF; Li, TT; Li, XY; Luo, SY; Zhang, GH; Zhou, LL1
Fuse, A; Kusano, T; Matsuda, Y; Okamoto, K; Suzuki, G; Yamaguchi, M; Yokota, H1
Annamalai, B; Choi, S; Singh, AK; Singh, I; Won, JS1
Ormstad, H; Sandvik, L; Verkerk, R1
Otsuka, S; Sakakima, H; Sumizono, M; Takada, S; Terashi, T; Yoshida, Y1
Dempsey, RJ; Kaimal, B; Kim, T; Lyons, K; Mehta, SL; Vemuganti, R1
Chen, J; Feng, W; Huang, S; Li, W; Li, X; Liang, C; Lin, L; Liu, C; Wang, Y; Wu, Y; Zhang, M1
Diaz-Ruiz, A; Montes, S; Nava-Ruiz, C; Orozco-Suarez, S; Ortiz-Plata, A; Pérez-Neri, I; Perez-Severiano, F; Ríos, C; Salgado-Ceballos, H; Zavala, C1
Ishida, A; Ishida-Nakajima, W; Kawamura, M; Miura, S; Oguma, R; Ohmura, A; Sato, Y; Takahashi, T1
Du, CP; Gao, J; Hou, XY; Liu, Y; Qi, J; Tai, JM; Wang, W1
Aguilera, P; Barrera, D; Chánez-Cárdenas, ME; Espinoza-Rojo, M; León-Aparicio, D; Maldonado, PD; Ortiz-Plata, A; Sánchez-García, A; Villeda-Hernández, J1
Caracuel, L; Jiménez-Altayó, F; Martínez-Revelles, S; Messeguer, A; Pérez-Asensio, FJ; Planas, AM; Vila, E1
Deng, KM; Lin, Q; Lu, Y; Niu, YY; Yao, LY; Zhang, JH1
Boiti, C; Borutti, G; Cazzaniga, M; Falaschi, F; Maestroni, A; Mandelli, C; Manganaro, D; Monzani, V; Rossi, P; Torgano, G; Zecca, B; Zilioli, E1
Fukumoto, K; Moriyama, Y; Takagi, N; Takeo, S; Tanonaka, K; Yamamoto, R1
Gozal, D; Guo, SZ; Lee, SK; Li, RC1
Liu, B; Liu, KJ; Liu, W; Schnell, A; Yuan, Z1
Cheng, CY; Ho, TY; Hsieh, CL; Lo, WY; Su, SY; Tang, NY1
Cheyuo, C; Coppa, G; Jacob, A; Wang, P; Wu, R; Zhou, M1
Bosnyak, E; Koller, A; Komoly, S; Marko, L; Nagy, J; Pusch, G; Szapary, L; Toth, P; Wittmann, I1
Kaundal, RK; Sharma, SS2
Doostkam, S; Meckel, S; Meyer, PT; Nikkhah, G; Prinz, M; Reithmeier, T; Rottenburger, C1
Li, L; Zuo, Z1
Daiber, A; Förstermann, U; Guo, L; Li, H; Lu, Q; Münzel, T; Wenzel, P; Xia, N; Xu, H1
Oberstrass, H; Ringelstein, A; Seitz, RJ; Siebler, M; Wittsack, HJ1
Andreescu, S; Aston, JW; Chatani, P; Erlichman, JS; Estevez, AY; Harper, K; Leiter, JC; Lucky, JJ; Ludington, JS; Lynch, A; Mosenthal, WP; Pritchard, S1
Baik, SK; Hwang, JC; Kwon, JH; Shin, SH; Weon, YC1
Fiebach, JB; Hamann, G; Hennerici, MG; Junghans, U; Röther, J; Schneider, D; Seitz, RJ; Siebler, M; Villringer, A; von Reutern, GM; Witte, OW1
Baĭsa, AE; Burov, SV; Chefu, SG; Leko, MV; Veselkina, OS; Vlasov, TD1
Baik, SK; Lee, JH; Oh, SJ; Park, KP1
Hamada, J; Hori, O; Kamide, T; Kawano, T; Kitao, Y; Mohri, H; Munesue, S; Okada, A; Schmidt, AM; Takeichi, T; Yamamoto, H; Yamamoto, Y1
Bang, OY; Byun, HS; Jeon, P; Kim, GM; Kim, JW; Kim, KH1
Alexandrov, AV; Bavarsad Shahripour, R1
Besshoh, S; Marunouchi, T; Takagi, N; Takeo, S; Tanonaka, K1
Bas, DF; Bodur, E; Dalkara, T; Gursoy-Ozdemir, Y; Saatci, I; Topcuoglu, MA1
Cao, L; Chao, XD; Fei, Z; Han, F; Lau, WB; Liu, W; Luo, P; Ma, YH; Ning, WD; Qu, Y; Su, N; Zhang, L; Zhao, BC; Zhu, J1
Meng, Q; Quirion, R; Sun, C; Wang, H; Zhang, L; Zheng, W1
Lamensdorf, I; Lavie, G; Leker, RR; Ovadia, H; Shohami, E; Teichner, A1
Hou, XY; Liu, Y; Xu, TL; Zhang, GY1
Li, H; Zhang, G; Zhang, Q1
Ma, J; Zhang, GY1
Fukunaga, K; Hamada, J; Hashiguchi, A; Kawano, T; Morioka, M; Sato, T; Shirasaki, Y; Ushio, Y; Yano, S1
Li, HC; Zhang, GY1
Sharma, SS; Thiyagarajan, M1
Aruga, T; Dohi, K; Ikeda, Y; Inn, R; Ohtaki, H; Shioda, HS1
Katayama, Y; Katsura, KI; Kurihara, J; Takahashi, K; Watanabe, M1
Haerten, K; Krabbe, C; Raiber, M1
Can, A; Dalkara, T; Gürsoy-Ozdemir, Y1
Aquilani, R; Arcidiaco, P; Arrigoni, N; Boschi, F; Dossena, M; Iadarola, P; Pastoris, O; Scocchi, M; Sessarego, P; Verri, M1
Ikeda, M; Suzuki, M; Tabuchi, M; Tomita, T; Umegaki, K1
Junghans, U; Meisel, S; Moll, M; Seitz, RJ; Siebler, M; Wittsack, HJ1
Kaul, CL; Sharma, SS; Thiyagarajan, M1
Hao, ZB; Liu, Y; Ma, J; Yan, JZ; Zhang, GY1
Gadian, DG; Latchman, DS; Lythgoe, MF; Ordidge, RJ; Proctor, E; Stephanou, A; Valentim, LM; van der Weerd, L; West, DA1
Albuquerque, FC; Deshmukh, VR; Fiorella, DJ; Flaster, M; Frey, J; McDougall, CG; Spetzler, RF; Wallace, RC1
Aoki, T; Maeda, M; Matsuoka, N; Mihara, K; Moriguchi, A; Mutoh, S1
Cho, GS; Chung, JH; Kim, HJ; Kim, WK; Lee, JC; Lim, JH; Nam, W; Oh, YK1
Coull, BM; McDonagh, PF; Ritter, LS; Stempel, KM1
Liu, Y; Xu, TL; Yan, JZ; Zhang, GY1
Schilling, L; Weinzierl, N; Woitzik, J1
Komine-Kobayashi, M; Liu, M; Mizuno, Y; Tanaka, R; Urabe, T; Zhang, N1
Dahmani, S; Gressens, P; Mantz, J; Rouelle, D1
Date, I; Kago, T; Takagi, K; Takagi, N; Takenaga, Y; Takeo, S1
Bukow, SC; Daffertshofer, M; Hennerici, MG1
Elango, C; Jatana, M; Khan, M; Paintlia, AS; Singh, AK; Singh, I1
Chen, YC; Chou, DS; Hsiao, G; Lin, CH; Lin, JH; Lin, KH; Sheu, JR1
Han, D; Wang, XT; Xu, TL; Yin, XH; Zhang, GY; Zhang, QG1
Del Pace, S; Scheggi, V1
Coenen, HH; Hamacher, K; Langen, KJ; Pauleit, D; Reifenberger, G; Sabel, M; Salber, D; Shah, NJ; Stoffels, G1
Alonso, D; Fernández, AP; Martínez, A; Martínez-Murillo, R; Mourelle, M; Rodrigo, J; Salas, E; Serrano, J1
Cheung, AK; Chiu, JF; Chung, SK; Chung, SS; He, QY; Hung, VK; Lo, AC; Yeung, CM1
Bacchetti, T; Mazzanti, L; Moroni, C; Nanetti, L; Provinciali, L; Raffaelli, F; Silvestrini, M; Taffi, R; Vignini, A1
Hong, KW; Kim, CD; Lee, JH; Lee, WS; Park, SY; Rhim, BY1
Blanco, S; Castro, L; Del Moral, ML; Hernández, R; Martínez-Lara, E; Pedrosa, JA; Peinado, MA; Siles, E1
Hou, XY; Liu, Y; Zhang, GY1
Han, D; Li, C; Wang, R; Yu, HM; Zhang, F; Zhang, GY; Zhang, QG; Zhou, C1
Björk-Eriksson, T; Blomgren, K; Eriksson, PS; Fukuda, A; Fukuda, H; Hagberg, H; Korhonen, L; Lannering, B; Lindholm, D; Nilsson, M; Northington, FJ; Wang, X; Xu, F; Zhu, C1
Kent, TA; Mandava, P; Thiagarajan, P1
Li, T; Yu, XJ; Zhang, GY1
Bading, H; Gass, P; Kiessling, M1
Au, KN; Gurd, JW1
Kindy, MS1
O'Regan, MH; Phillis, JW; Song, D1
Beckman, JS; Chen, J; Conger, KA; Ye, YZ1
Galbraith, SL; MacKay, KB; McCulloch, J; Patel, TR; Woodruff, GN1
Hayashi, H; Miyake, K; Oshikawa, S; Tadokoro, M; Takagi, K; Takagi, N; Takeo, S1
Barroso, CP; Caldas, MC; Cunha e Sá, M; Edvinsson, L; Gulbenkian, S1
Bruce-Keller, AJ; Germeyer, A; Holtsberg, FW; Hutchins, JB; Keller, JN; Kindy, MS; Mattson, MP; St Clair, DK; Steiner, SM; Yen, HC1
Fukuyama, N; Hirabayashi, H; Nakazawa, H; Shinohara, Y; Takizawa, S3
Hisatsune, C; Mishina, M; Umemori, H; Yamamoto, T1
Ben-Ari, Y; Benjelloun, N; Charriaut-Marlangue, C; Ducrocq, S; Plotkine, M1
Ahmed, SH; Beckman, JS; Chen, SW; Goldberg, MP; He, L; Hsu, CY; Xu, J1
Calabrò, G; Caputi, AP; Costantino, G; Cucinotta, G; Cuzzocrea, S; De Sarro, A; Dugo, L; Mazzon, E; Serraino, I1
Bhat, RV; Correll, MP; Fieles, WE; Keith, RA; Lee, CM; Scott, CW; Shanley, J1
Barberi, I; Caputi, AP; Cordaro, S; Costantino, G; Cuzzocrea, S; De Sarro, A; Fulia, F; Gitto, E; Mazzon, E; Serraino, I1
Fukuyama, N; Ishida, H; Nakazawa, H; Takizawa, S; Tsuji, C; Yoshitake, M1
Bose, R; Derrick, M; Tan, S1
Gao, C; Hou, X; Liu, Y; Zhang, G1
Bémeur, C; Butterworth, R; Hazell, AS; Montgomery, J; Ste-Marie, L1
Choi, CR; Choi, JW; Jang, ES; Ju, C; Kim, HC; Kim, WK; Ko, KH; Shin, CY1
Alonso, D; Bentura, ML; Castro-Blanco, S; Encinas, JM; Fernández, AP; Fernández-Vizarra, P; Richart, A; Rodrigo, J; Rodríguez, I; Ruíz-Cabello, J; Santacana, M; Serrano, J; Uttenthal, LO1
Fink, GR; Freund, HJ; Junghans, U; Ritzl, A; Seitz, RJ; Siebler, M; Wittsack, HJ1
Li, Y; Pei, L; Zhang, GY1
Elsinga, PH; Go, KG; Kamman, RL; Molenaar, WM; Paans, AM; Prenen, GH; Sebens, JB; Vaalburg, W; Zijlstra, S; Zuiderveen, F1

Reviews

7 review(s) available for tyrosine and Brain Ischemia

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2014, Mar-08, Issue:3

    Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Brain Ischemia; Humans; Immunoglobulin Fab Fragments; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Tyrosine

2014
Protein tyrosine phosphorylation in the ischemic brain.
    Journal of pharmacological sciences, 2014, Volume: 125, Issue:4

    Topics: Angiopoietins; Animals; Brain Ischemia; Carrier Proteins; Ephrins; Homer Scaffolding Proteins; Humans; Intercellular Signaling Peptides and Proteins; Molecular Targeted Therapy; Nerve Growth Factors; Occludin; Phosphorylation; Protein-Tyrosine Kinases; Receptors, Eph Family; Receptors, Glutamate; Tyrosine

2014
Ancillary approaches to plasminogen activators.
    Annals of the New York Academy of Sciences, 2012, Volume: 1268

    Topics: Anticoagulants; Arginine; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Collateral Circulation; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Hypothermia, Induced; Low-Level Light Therapy; Pipecolic Acids; Plasminogen Activators; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Sulfonamides; Thrombolytic Therapy; Tirofiban; Tyrosine; Ultrasonic Therapy; Vasodilator Agents

2012
Tirofiban for the treatment of ischaemic stroke.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:1

    Topics: Animals; Brain Ischemia; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine

2006
Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.
    Drugs, 2008, Volume: 68, Issue:8

    Topics: Abciximab; Acute Disease; Animals; Antibodies, Monoclonal; Brain Ischemia; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine

2008
Nitrotyrosine formation and its role in various pathological conditions.
    Free radical research, 2000, Volume: 33, Issue:6

    Topics: Animals; Brain Ischemia; Cell Survival; Cells, Cultured; Coculture Techniques; Disease; Dogs; Endothelium, Vascular; Lung Diseases; Male; Myocardium; Neutrophils; Radiation Injuries; Rats; Reperfusion Injury; Tyrosine

2000

Trials

6 trial(s) available for tyrosine and Brain Ischemia

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Cerebrovascular diseases (Basel, Switzerland), 2010, Volume: 29, Issue:3

    Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intracranial Hemorrhages; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recovery of Function; Stroke; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2010
Failed recovery from thrombolysis is predicted by the initial diffusion weighted imaging lesion.
    Cerebrovascular diseases (Basel, Switzerland), 2011, Volume: 31, Issue:6

    Topics: Aged; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recovery of Function; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Tyrosine

2011
Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
    Stroke, 2011, Volume: 42, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Radiography; Stroke; Time Factors; Tirofiban; Tyrosine

2011
The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions.
    Neurology, 2004, Jun-08, Volume: 62, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Brain; Brain Ischemia; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Image Processing, Computer-Assisted; Infarction, Middle Cerebral Artery; Magnesium; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine

2004
Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban.
    Neurology, 2002, Feb-12, Volume: 58, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Brain Infarction; Brain Ischemia; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Tirofiban; Tyrosine

2002

Other Studies

120 other study(ies) available for tyrosine and Brain Ischemia

ArticleYear
Tyrosine Phosphorylation of the K
    International journal of molecular sciences, 2020, Dec-15, Volume: 21, Issue:24

    Topics: 2,2'-Dipyridyl; Animals; Apoptosis; Brain Ischemia; Cell Survival; Disulfides; HEK293 Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mutation; Neurons; Oxidative Stress; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Rats; Shab Potassium Channels; Tyrosine

2020
Identification and relative quantification of 3-nitrotyrosine residues in fibrinogen nitrated in vitro and fibrinogen from ischemic stroke patient plasma using LC-MS/MS.
    Free radical biology & medicine, 2021, Volume: 165

    Topics: Brain Ischemia; Chromatography, Liquid; Fibrinogen; Hemostatics; Humans; Ischemic Stroke; Nitrates; Stroke; Tandem Mass Spectrometry; Tyrosine

2021
Controlled arterial reflow after ischemia induces better outcomes in the juvenile rat brain.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:9

    Topics: Animals; Brain Ischemia; Cell Death; Cerebral Arteries; Cerebrovascular Circulation; Cyclooxygenase 2; Disease Models, Animal; Prostaglandin-E Synthases; Rats, Wistar; Reperfusion; Reperfusion Injury; Treatment Outcome; Tyrosine; Ultrasonography

2017
Peroxynitrite-Induced Tyrosine Nitration Contributes to Matrix Metalloprotease-3 Activation: Relevance to Hyperglycemic Ischemic Brain Injury and Tissue Plasminogen Activator.
    Neurochemical research, 2018, Volume: 43, Issue:2

    Topics: Animals; Brain; Brain Ischemia; Cerebral Hemorrhage; Disease Models, Animal; Male; Matrix Metalloproteinase 3; Peroxynitrous Acid; Rats, Wistar; Reperfusion Injury; Tissue Plasminogen Activator; Tyrosine

2018
Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy.
    Stroke, 2017, Volume: 48, Issue:12

    Topics: Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Endpoint Determination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Registries; Risk Factors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine

2017
Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
    Journal of the neurological sciences, 2017, Dec-15, Volume: 383

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Cerebral Angiography; Cerebral Hemorrhage; Computed Tomography Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Proof of Concept Study; Stroke; Time Factors; Time-to-Treatment; Tirofiban; Treatment Outcome; Tyrosine

2017
Chrysophanol attenuates nitrosative/oxidative stress injury in a mouse model of focal cerebral ischemia/reperfusion.
    Journal of pharmacological sciences, 2018, Volume: 138, Issue:1

    Topics: Animals; Anthraquinones; Apoptosis; Brain; Brain Ischemia; Caspase 3; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide; Nitrosation; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase; Tyrosine

2018
IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke.
    JCI insight, 2018, 09-20, Volume: 3, Issue:18

    Topics: Animals; Brain Injuries; Brain Ischemia; Cytokines; Disease Models, Animal; Inflammation; Interleukin-10; Interleukin-33; Interleukin-4; Lung; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Stroke; Th1 Cells; Th2 Cells; Treatment Outcome; Tyrosine

2018
Sevoflurane preconditioning induces tolerance to brain ischemia partially via inhibiting thioredoxin-1 nitration.
    BMC anesthesiology, 2018, 11-17, Volume: 18, Issue:1

    Topics: Administration, Inhalation; Animals; Brain Ischemia; Humans; Ischemic Preconditioning; Male; Nitrates; Platelet Aggregation Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Sevoflurane; Thioredoxins; Tyrosine

2018
Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Cerebrovascular diseases (Basel, Switzerland), 2013, Volume: 35, Issue:5

    Topics: Abciximab; Aged; Antibodies, Monoclonal; Atrial Fibrillation; Brain Ischemia; Combined Modality Therapy; Comorbidity; Female; Fibrinolytic Agents; Humans; Hypertension; Immunoglobulin Fab Fragments; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Mechanical Thrombolysis; Middle Aged; Neuroimaging; Prognosis; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Single-Blind Method; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator

2013
Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke.
    Journal of molecular neuroscience : MN, 2013, Volume: 51, Issue:3

    Topics: Aged; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Catecholamines; Cytokines; Female; Glucose; Humans; Inflammation; Male; Middle Aged; Stroke; Tryptophan; Tyrosine

2013
Capacity of HSYA to inhibit nitrotyrosine formation induced by focal ischemic brain injury.
    Nitric oxide : biology and chemistry, 2013, Nov-30, Volume: 35

    Topics: Animals; Brain Ischemia; Chalcone; Gene Expression; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Quinones; Rats; Rats, Sprague-Dawley; Tyrosine

2013
Cytochrome C is tyrosine 97 phosphorylated by neuroprotective insulin treatment.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Cell Survival; Cytochromes c; Gene Expression; Insulin; Mitochondria; Neurons; Neuroprotective Agents; Phosphorylation; Protein Processing, Post-Translational; Rats; Signal Transduction; Spectrometry, Mass, Electrospray Ionization; Swine; Tyrosine

2013
Tim-3 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats.
    Metabolic brain disease, 2015, Volume: 30, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cyclooxygenase 2; Ischemic Postconditioning; Male; Minocycline; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Signal Transduction; Tyrosine

2015
Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban.
    Cerebrovascular diseases (Basel, Switzerland), 2014, Volume: 37, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine

2014
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine.
    Toxicology and applied pharmacology, 2014, Sep-15, Volume: 279, Issue:3

    Topics: Animals; Biphenyl Compounds; Blotting, Western; Brain; Brain Ischemia; Cell Death; Endoplasmic Reticulum Stress; Immunohistochemistry; Indicators and Reagents; Ischemic Attack, Transient; Lignans; Male; Neurons; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase Type II; Oncogene Protein v-akt; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stroke; Transcription Factor CHOP; Tyrosine

2014
Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine.
    International journal of molecular sciences, 2014, Aug-27, Volume: 15, Issue:9

    Topics: Animals; Basidiomycota; Brain Ischemia; CCAAT-Enhancer-Binding Proteins; Cell Death; Cytokines; Diterpenes; Male; Mycelium; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Transcription Factor CHOP; Tyrosine

2014
Tyrosine phosphorylation of GluK2 up-regulates kainate receptor-mediated responses and downstream signaling after brain ischemia.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-23, Volume: 111, Issue:38

    Topics: Animals; Brain Ischemia; GluK2 Kainate Receptor; HEK293 Cells; Hippocampus; Humans; Male; Mitogen-Activated Protein Kinase 10; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Signal Transduction; src-Family Kinases; Stroke; Tyrosine; Up-Regulation

2014
Activity increase in EpoR and Epo expression by intranasal recombinant human erythropoietin (rhEpo) administration in ischemic hippocampi of adult rats.
    Neuroscience letters, 2014, Nov-07, Volume: 583

    Topics: Administration, Intranasal; Animals; Brain Ischemia; Cell Survival; Cytoprotection; Erythropoietin; Hippocampus; Humans; Male; Neuroprotective Agents; Phosphorylation; Rats, Wistar; Receptors, Erythropoietin; Recombinant Proteins; Tyrosine

2014
MicroRNA-23a-3p attenuates oxidative stress injury in a mouse model of focal cerebral ischemia-reperfusion.
    Brain research, 2014, Dec-10, Volume: 1592

    Topics: Animals; Brain; Brain Ischemia; Caspase 3; Cell Line; Disease Models, Animal; Hydrogen Peroxide; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Male; Mice, Inbred C57BL; MicroRNAs; Nitric Oxide; Oxidative Stress; Reperfusion Injury; Superoxide Dismutase; Transfection; Tyrosine; Up-Regulation

2014
Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice.
    Journal of neuroscience research, 2015, Volume: 93, Issue:4

    Topics: Aldehydes; Analysis of Variance; Animals; Brain; Brain Ischemia; Carotenoids; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Matrix Metalloproteinases; Mice; Nervous System Diseases; Neuroprotective Agents; Obesity; Oxidative Stress; Reperfusion; Tyrosine; Vitamin A

2015
Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death.
    Biochimica et biophysica acta, 2015, Volume: 1852, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Brain; Brain Ischemia; Caspase 3; Cell Line, Tumor; Enzyme Activation; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neurons; Rats; Rats, Sprague-Dawley; Stroke; Tyrosine

2015
A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.
    British journal of pharmacology, 2015, Volume: 172, Issue:15

    Topics: Animals; Bleeding Time; Blood Platelets; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Crotalid Venoms; Dose-Response Relationship, Drug; Fibrin; Infarction, Middle Cerebral Artery; Lectins, C-Type; Male; Mice; Platelet Glycoprotein GPIb-IX Complex; Protective Agents; Reperfusion Injury; Stroke; Tirofiban; Tyrosine; von Willebrand Factor

2015
The Effects of Xanthine Oxidoreductase Inhibitors on Oxidative Stress Markers following Global Brain Ischemia Reperfusion Injury in C57BL/6 Mice.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Aldehydes; Allopurinol; Animals; Biomarkers; Brain; Brain Ischemia; Disease Models, Animal; Interleukin-1beta; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; RNA, Messenger; Tumor Necrosis Factor-alpha; Tyrosine; Uric Acid; Xanthine Dehydrogenase

2015
S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.
    Brain research, 2015, Oct-22, Volume: 1624

    Topics: Analysis of Variance; Animals; Brain; Brain Ischemia; Calpain; Chronic Disease; Cyclin-Dependent Kinase 5; Disease Models, Animal; Glycogen Synthase Kinase 3; Neuroprotective Agents; Phosphorylation; Rats; S-Nitrosoglutathione; Synaptosomes; tau Proteins; Tyrosine

2015
Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?
    Journal of molecular neuroscience : MN, 2016, Volume: 58, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Humans; Male; Middle Aged; Phenylalanine; Stroke; Tyrosine

2016
The neuroprotective effects of preconditioning exercise on brain damage and neurotrophic factors after focal brain ischemia in rats.
    Behavioural brain research, 2016, Apr-15, Volume: 303

    Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Caspase 3; Cytokines; Glial Fibrillary Acidic Protein; Infarction, Middle Cerebral Artery; Male; Midkine; Nerve Growth Factors; Physical Conditioning, Animal; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Tyrosine

2016
Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 06-29, Volume: 36, Issue:26

    Topics: alpha-Synuclein; Animals; Brain Infarction; Brain Ischemia; Caspase 3; Death-Associated Protein Kinases; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Motor Activity; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; RNA, Small Interfering; Stroke; Tyrosine

2016
Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
    Stroke, 2016, Volume: 47, Issue:10

    Topics: Aged; Brain; Brain Ischemia; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine

2016
Antioxidant, antiinflammatory and antiapoptotic effects of dapsone in a model of brain ischemia/reperfusion in rats.
    Journal of neuroscience research, 2008, Nov-15, Volume: 86, Issue:15

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Brain Ischemia; Caspase 3; Caspase 9; Chromatography, High Pressure Liquid; Dapsone; Immunoblotting; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Neuroprotective Agents; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine

2008
Ascorbic acid protects the newborn rat brain from hypoxic-ischemia.
    Brain & development, 2009, Volume: 31, Issue:4

    Topics: Analysis of Variance; Animals; Animals, Newborn; Antioxidants; Apoptosis; Ascorbic Acid; Blotting, Western; Brain; Brain Ischemia; Calpain; Carrier Proteins; Caspase 3; Enzyme Activation; In Situ Nick-End Labeling; Microfilament Proteins; Microscopy, Electron; Necrosis; Neurons; Neuroprotective Agents; Rats; Tyrosine

2009
Increased tyrosine phosphorylation of PSD-95 by Src family kinases after brain ischaemia.
    The Biochemical journal, 2009, Jan-01, Volume: 417, Issue:1

    Topics: Animals; Binding Sites; Brain Ischemia; Cells, Cultured; Chlorocebus aethiops; COS Cells; Disks Large Homolog 4 Protein; Glutamic Acid; Hippocampus; Immunoblotting; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mutation; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; src-Family Kinases; Tyrosine

2009
Aged garlic extract delays the appearance of infarct area in a cerebral ischemia model, an effect likely conditioned by the cellular antioxidant systems.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2010, Volume: 17, Issue:3-4

    Topics: Animals; Antioxidants; Brain; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Garlic; Glutathione Peroxidase; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Tyrosine

2010
Participation of oxidative stress on rat middle cerebral artery changes induced by focal cerebral ischemia: beneficial effects of 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6).
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:2

    Topics: Animals; Benzopyrans; Body Weight; Brain Ischemia; Fluorescent Antibody Technique; Free Radical Scavengers; Male; Middle Cerebral Artery; Myography; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Reactive Oxygen Species; Tyrosine; Vitamin E

2009
Synthesis of Lipoamino acids and their activity against cerebral ischemic injury.
    Molecules (Basel, Switzerland), 2009, Oct-12, Volume: 14, Issue:10

    Topics: Anaerobiosis; Animals; Brain; Brain Ischemia; Hydrogen Peroxide; Neuroprotective Agents; Rats; Serine; Threonine; Tyrosine

2009
Prostanoid EP1 receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia.
    European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

    Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Capillaries; Capillary Permeability; Fluorescein-5-isothiocyanate; Hydrazines; Male; Membrane Proteins; Occludin; Oxazepines; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Serum Albumin; Tyrosine

2010
Neuroglobin protects neurons against oxidative stress in global ischemia.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2010, Volume: 30, Issue:11

    Topics: Animals; Brain Ischemia; Catalase; Globins; Glutathione Peroxidase; Hippocampus; Humans; Lipid Peroxidation; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neuroglobin; Neurons; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase; Tyrosine; Up-Regulation

2010
Normobaric hyperoxia delays and attenuates early nitric oxide production in focal cerebral ischemic rats.
    Brain research, 2010, Sep-17, Volume: 1352

    Topics: Animals; Brain Ischemia; Cerebral Infarction; Hyperoxia; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Nitrates; Nitric Acid; Nitrites; Rats; Rats, Sprague-Dawley; Tyrosine

2010
Ferulic acid inhibits nitric oxide-induced apoptosis by enhancing GABA(B1) receptor expression in transient focal cerebral ischemia in rats.
    Acta pharmacologica Sinica, 2010, Volume: 31, Issue:8

    Topics: Animals; Apoptosis; Brain Ischemia; Coumaric Acids; Disease Models, Animal; Free Radical Scavengers; Gene Expression Regulation; Male; Neuroprotective Agents; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Reperfusion Injury; Tyrosine

2010
Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve.
    Shock (Augusta, Ga.), 2011, Volume: 35, Issue:3

    Topics: Animals; Apoptosis; Brain Ischemia; Ghrelin; Humans; Immunohistochemistry; Inflammation; Interleukin-6; Male; Matrix Metalloproteinase 9; Neutrophils; Nitric Oxide Synthase Type I; Peroxidase; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; Tyrosine; Vagotomy; Vagus Nerve

2011
Microalbuminuria, indicated by total versus immunoreactive urinary albumins, in acute ischemic stroke patients.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2011, Volume: 20, Issue:6

    Topics: Aged; Albuminuria; Biomarkers; Brain Ischemia; Chi-Square Distribution; Chromatography, High Pressure Liquid; Creatinine; Humans; Hungary; Immunoassay; Linear Models; Nephelometry and Turbidimetry; Predictive Value of Tests; Prevalence; Prognosis; Severity of Illness Index; Stroke; Tyrosine

2011
GW1929: a nonthiazolidinedione PPARγ agonist, ameliorates neurological damage in global cerebral ischemic-reperfusion injury through reduction in inflammation and DNA fragmentation.
    Behavioural brain research, 2011, Jan-20, Volume: 216, Issue:2

    Topics: Analysis of Variance; Animals; Benzophenones; Brain Damage, Chronic; Brain Ischemia; Cognition Disorders; DNA Fragmentation; Gerbillinae; Hippocampus; Male; Motor Activity; Neuroprotective Agents; PPAR gamma; Reperfusion Injury; Tyrosine

2011
Interesting image. Amino acid PET tracer accumulation in cortical ischemia: an interesting case.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:11

    Topics: Brain Ischemia; Humans; Male; Middle Aged; Positron-Emission Tomography; Radioactive Tracers; Tyrosine

2010
Glutamate transporter type 3 knockout reduces brain tolerance to focal brain ischemia in mice.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2011, Volume: 31, Issue:5

    Topics: Aldehydes; Animals; Blotting, Western; Brain Ischemia; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Transporter 3; Glutathione; Male; Mice; Mice, Knockout; Tyrosine

2011
Betulinic acid protects against cerebral ischemia-reperfusion injury in mice by reducing oxidative and nitrosative stress.
    Nitric oxide : biology and chemistry, 2011, Apr-30, Volume: 24, Issue:3

    Topics: Animals; Betulinic Acid; Brain; Brain Ischemia; Male; Mice; Mice, Knockout; NADPH Oxidases; Nitric Oxide Synthase; Oxidative Stress; Pentacyclic Triterpenes; Reactive Nitrogen Species; Reperfusion Injury; RNA, Messenger; Stress, Physiological; Triterpenes; Tyrosine

2011
Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia.
    Free radical biology & medicine, 2011, Sep-15, Volume: 51, Issue:6

    Topics: Animals; Apoptosis; Brain Ischemia; Cerium; Disease Models, Animal; Free Radical Scavengers; Hippocampus; Mice; Nanoparticles; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Superoxides; Tyrosine

2011
Ameliorative effects of GW1929, a nonthiazolidinedione PPARγ agonist, on inflammation and apoptosis in focal cerebral ischemic-reperfusion injury.
    Current neurovascular research, 2011, Aug-01, Volume: 8, Issue:3

    Topics: Animals; Apoptosis; Benzophenones; Brain Ischemia; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; In Situ Nick-End Labeling; Inflammation; Male; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tyrosine

2011
Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
    Neuroradiology, 2011, Volume: 53, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Recovery of Function; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator

2011
[Amides of creatine: perspectives of neuroprotection].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2011, Volume: 97, Issue:7

    Topics: Amides; Animals; Brain Ischemia; Creatine; Female; gamma-Aminobutyric Acid; Glycine; Hemodynamics; Image Processing, Computer-Assisted; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Injections, Intravenous; Ischemic Attack, Transient; Male; Microscopy; Microtomy; Models, Animal; Neuroprotective Agents; Phenylalanine; Rats; Rats, Wistar; Tetrazolium Salts; Tyrosine

2011
Intra-arterial tirofiban infusion for partial recanalization with stagnant flow in hyperacute cerebral ischemic stroke.
    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2011, Volume: 17, Issue:4

    Topics: Acute Disease; Adult; Blood Flow Velocity; Brain Ischemia; Cerebral Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2011
RAGE mediates vascular injury and inflammation after global cerebral ischemia.
    Neurochemistry international, 2012, Volume: 60, Issue:3

    Topics: Animals; Brain Ischemia; Carotid Artery Injuries; Cell Death; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neuroglia; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Real-Time Polymerase Chain Reaction; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Stroke; Tumor Necrosis Factor-alpha; Tyrosine; Vascular System Injuries

2012
Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator

2012
Effects of metabotropic glutamate mGlu5 receptor antagonist on tyrosine phosphorylation of NMDA receptor subunits and cell death in the hippocampus after brain ischemia in rats.
    Neuroscience letters, 2012, Nov-14, Volume: 530, Issue:1

    Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Cell Death; Excitatory Amino Acid Antagonists; Male; Phosphorylation; Pyridines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; src-Family Kinases; Tyrosine

2012
Plasma 3-nitrotyrosine estimates the reperfusion-induced cerebrovascular stress, whereas matrix metalloproteinases mainly reflect plasma activity: a study in patients treated with thrombolysis or endovascular recanalization.
    Journal of neurochemistry, 2012, Volume: 123 Suppl 2

    Topics: Adult; Aged; Brain Ischemia; Cerebral Angiography; Diffusion Magnetic Resonance Imaging; Endovascular Procedures; Female; Humans; Male; Matrix Metalloproteinase 2; Middle Aged; Oxidative Stress; Reperfusion Injury; Thrombolytic Therapy; Time Factors; Tomography, X-Ray Computed; Tyrosine; Ultrasonography, Doppler, Transcranial

2012
Up-regulation of heme oxygenase-1 attenuates brain damage after cerebral ischemia via simultaneous inhibition of superoxide production and preservation of NO bioavailability.
    Experimental neurology, 2013, Volume: 239

    Topics: Animals; Blotting, Western; Brain Ischemia; Dependovirus; Genetic Therapy; Genetic Vectors; Heme Oxygenase-1; Infarction, Middle Cerebral Artery; Male; Nervous System Diseases; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Reactive Oxygen Species; Superoxides; Tyrosine; Up-Regulation

2013
Glutamate attenuates IGF-1 receptor tyrosine phosphorylation in mouse brain: possible significance in ischemic brain damage.
    Neuroscience research, 2012, Volume: 74, Issue:3-4

    Topics: Animals; Brain; Brain Ischemia; Glutamic Acid; Humans; Insulin-Like Growth Factor I; Male; Mice; Phosphorylation; Receptor, IGF Type 1; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tyrosine

2012
The nitroxide antioxidant tempol is cerebroprotective against focal cerebral ischemia in spontaneously hypertensive rats.
    Experimental neurology, 2002, Volume: 176, Issue:2

    Topics: Animals; Antioxidants; Behavior, Animal; Body Weight; Brain; Brain Chemistry; Brain Ischemia; Cyclic N-Oxides; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Infarction, Middle Cerebral Artery; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Rats; Rats, Inbred SHR; Spin Labels; Treatment Outcome; Tyrosine

2002
L-type voltage-gated calcium channel attends regulation of tyrosine phosphorylation of NMDA receptor subunit 2A induced by transient brain ischemia.
    Brain research, 2003, May-16, Volume: 972, Issue:1-2

    Topics: Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Focal Adhesion Kinase 2; Hippocampus; Immunoblotting; Male; Nifedipine; Phosphorus Isotopes; Phosphotyrosine; Precipitin Tests; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion; src-Family Kinases; Tyrosine

2003
Signal transducer and activator of transcription-3 activation is mediated by N-methyl-D-aspartate receptor and L-type voltage-gated Ca2+ channel during cerebral ischemia in rat hippocampus.
    Neuroscience letters, 2003, Jul-10, Volume: 345, Issue:1

    Topics: Active Transport, Cell Nucleus; Animals; Brain Ischemia; Calcium Channel Blockers; Calcium Channels, L-Type; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Hippocampus; Immunoblotting; Ketamine; Male; Nifedipine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; STAT3 Transcription Factor; Trans-Activators; Tyrosine

2003
Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia.
    Neuroscience letters, 2003, Sep-18, Volume: 348, Issue:3

    Topics: Animals; Brain Ischemia; Disks Large Homolog 4 Protein; Hippocampus; Intracellular Signaling Peptides and Proteins; Lithium; Male; Membrane Proteins; Nerve Tissue Proteins; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; src-Family Kinases; Tyrosine

2003
The neuroprotective effect of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, in transient forebrain ischemia.
    Neuroscience, 2003, Volume: 121, Issue:2

    Topics: Animals; Blotting, Western; Brain Ischemia; Calmodulin; Carotid Artery, Internal, Dissection; Chromatography, High Pressure Liquid; Disease Models, Animal; Enzyme Inhibitors; Gerbillinae; Hippocampus; Immunohistochemistry; Indazoles; Ischemic Attack, Transient; Male; Microdialysis; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Reperfusion; Time Factors; Tyrosine

2003
Inhibitory effect of genistein on activation of STAT3 induced by brain ischemia/reperfusion in rat hippocampus.
    Acta pharmacologica Sinica, 2003, Volume: 24, Issue:11

    Topics: Animals; Brain Ischemia; DNA-Binding Proteins; Genistein; Hippocampus; Male; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Reperfusion Injury; STAT3 Transcription Factor; Trans-Activators; Tyrosine

2003
Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Life sciences, 2004, Jan-09, Volume: 74, Issue:8

    Topics: Animals; Behavior, Animal; Body Temperature; Brain; Brain Edema; Brain Ischemia; Cerebrovascular Circulation; Curcumin; Fluorescent Antibody Technique; Glutathione Peroxidase; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Male; Neuroprotective Agents; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tyrosine

2004
Peroxynitrite and caspase-3 expression after ischemia/reperfusion in mouse cardiac arrest model.
    Acta neurochirurgica. Supplement, 2003, Volume: 86

    Topics: Animals; Brain Ischemia; Caspase 3; Caspases; Heart Arrest, Induced; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Peroxynitrous Acid; Reperfusion Injury; Time Factors; Tyrosine

2003
FK506 attenuates the post-ischemic perturbation of protein kinases and tyrosine phosphorylation in the gerbil hippocampal CA1 sectors.
    Acta neurochirurgica. Supplement, 2003, Volume: 86

    Topics: Animals; Brain Ischemia; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Gerbillinae; Hippocampus; Immunosuppressive Agents; Male; Phosphorylation; Phosphotyrosine; Protein Kinase C; Protein Kinases; Tacrolimus; Tissue Distribution; Tyrosine

2003
[Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice].
    Deutsche medizinische Wochenschrift (1946), 2004, Mar-19, Volume: 129, Issue:12

    Topics: Adult; Aged; Anticoagulants; Aspirin; Brain; Brain Ischemia; Carotid Arteries; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Eptifibatide; Female; Heparin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stroke; Ticlopidine; Tirofiban; Tomography, X-Ray Computed; Tyrosine; Ultrasonography, Doppler

2004
Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia.
    Stroke, 2004, Volume: 35, Issue:6

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Coloring Agents; Enzyme Inhibitors; Evans Blue; Matrix Metalloproteinase 9; Mice; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Peroxynitrous Acid; Reperfusion Injury; Superoxides; Tyrosine

2004
Plasma precursors of brain catecholaminergic and serotonergic neurotransmitters in rehabilitation patients with ischemic stroke.
    Archives of physical medicine and rehabilitation, 2004, Volume: 85, Issue:5

    Topics: Aged; Brain Ischemia; Case-Control Studies; Humans; Male; Nutritional Status; Stroke; Stroke Rehabilitation; Tryptophan; Tyrosine

2004
Protective effects of green tea catechins on cerebral ischemic damage.
    Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:6

    Topics: Animals; Brain Ischemia; Catechin; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Infarction, Middle Cerebral Artery; Interleukin-3; Male; Malondialdehyde; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Plant Extracts; Rats; Rats, Wistar; Recombinant Fusion Proteins; Recombinant Proteins; Tea; Tyrosine

2004
Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
    British journal of pharmacology, 2004, Volume: 142, Issue:5

    Topics: Animals; Apoptosis; Brain; Brain Edema; Brain Ischemia; Catalysis; DNA Fragmentation; Fluorescent Antibody Technique; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Kinetics; Male; Metalloporphyrins; Microscopy, Electron; Middle Cerebral Artery; Nervous System Diseases; Neuroprotective Agents; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Tyrosine

2004
Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia.
    Neuroscience research, 2004, Volume: 49, Issue:4

    Topics: Animals; Brain Ischemia; Disks Large Homolog 4 Protein; Focal Adhesion Kinase 2; Hippocampus; Immunoblotting; Intracellular Signaling Peptides and Proteins; Lithium; Male; Membrane Proteins; Nerve Tissue Proteins; Phosphorylation; Precipitin Tests; Proline; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; src-Family Kinases; Time Factors; Tyrosine

2004
MR image-guided investigation of regional signal transducers and activators of transcription-1 activation in a rat model of focal cerebral ischemia.
    Neuroscience, 2004, Volume: 127, Issue:2

    Topics: Animals; Body Water; Brain; Brain Ischemia; Cerebrovascular Circulation; Diffusion; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; DNA-Binding Proteins; fas Receptor; Functional Laterality; Infarction, Middle Cerebral Artery; Phosphorylation; Rats; Rats, Sprague-Dawley; Reaction Time; Reperfusion Injury; STAT1 Transcription Factor; Trans-Activators; Tyrosine; Up-Regulation

2004
Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy.
    Neurosurgery, 2005, Volume: 56, Issue:1

    Topics: Abciximab; Acute Disease; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Brain Ischemia; Chemotherapy, Adjuvant; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine

2005
FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2005, Volume: 25, Issue:1

    Topics: Animals; Blood Platelets; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Infarction, Middle Cerebral Artery; Intracranial Thrombosis; Male; Microcirculation; Neutrophils; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Propionates; Recovery of Function; Reperfusion Injury; Tirofiban; Tyrosine

2005
Accelerated cerebral ischemic injury by activated macrophages/microglia after lipopolysaccharide microinjection into rat corpus callosum.
    Glia, 2005, Apr-15, Volume: 50, Issue:2

    Topics: Animals; Brain Ischemia; Corpus Callosum; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Glutathione; Immunohistochemistry; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Microglia; Microinjections; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organic Chemicals; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tyrosine

2005
Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion.
    Biological research for nursing, 2005, Volume: 6, Issue:4

    Topics: Analysis of Variance; Animals; Anticoagulants; Biomarkers; Blood Platelets; Brain Ischemia; Disease Models, Animal; Flow Cytometry; Inflammation; Leukocytes; Male; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Polysaccharides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Tirofiban; Tyrosine

2005
Suppression of Pyk2 attenuated the increased tyrosine phosphorylation of NMDA receptor subunit 2A after brain ischemia in rat hippocampus.
    Neuroscience letters, 2005, Apr-29, Volume: 379, Issue:1

    Topics: Animals; Blotting, Western; Brain Ischemia; Disease Models, Animal; Focal Adhesion Kinase 2; Hippocampus; Immunoprecipitation; Male; Neural Inhibition; Oligodeoxyribonucleotides, Antisense; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; src-Family Kinases; Tyrosine

2005
Early administration of a second-generation perfluorochemical decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat.
    Neurological research, 2005, Volume: 27, Issue:5

    Topics: Analysis of Variance; Animals; Blood Gas Analysis; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Drug Therapy, Combination; Fluorocarbons; Immunohistochemistry; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Necrosis; Neuroprotective Agents; Oxygen; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Silver Staining; Time Factors; Tyrosine

2005
Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.
    Stroke, 2005, Volume: 36, Issue:10

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Anti-Inflammatory Agents; Antioxidants; Antipyrine; Brain; Brain Ischemia; Deoxyguanosine; DNA Damage; Edaravone; Electrophoresis, Polyacrylamide Gel; Free Radical Scavengers; Immunoblotting; Immunohistochemistry; Inflammation; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Reperfusion Injury; Time Factors; Tyrosine

2005
Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions.
    Anesthesiology, 2005, Volume: 103, Issue:5

    Topics: Adrenergic alpha-Agonists; Animals; Blotting, Western; Brain Ischemia; Caspase 3; Caspase Inhibitors; Cell Count; Cell Death; Cyclic AMP-Dependent Protein Kinases; Dexmedetomidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; Glucose; Hippocampus; Hydrogen-Ion Concentration; Hypnotics and Sedatives; Hypoxia; Ischemic Preconditioning; Male; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tyrosine

2005
Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries.
    Biochemical and biophysical research communications, 2006, Jan-27, Volume: 339, Issue:4

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Capillaries; Male; Membrane Proteins; Occludin; Phosphorylation; Rats; Rats, Wistar; Tight Junctions; Tyrosine

2006
Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke.
    Nitric oxide : biology and chemistry, 2006, Volume: 15, Issue:2

    Topics: Animals; Brain Chemistry; Brain Ischemia; Glutathione; Glutathione Disulfide; Lipid Peroxidation; Lipids; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Stroke; Structure-Activity Relationship; Tyrosine

2006
Inhibitory mechanisms of tetramethylpyrazine in middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia in rats.
    Planta medica, 2006, Volume: 72, Issue:5

    Topics: Animals; Brain Ischemia; Dose-Response Relationship, Drug; Free Radical Scavengers; Infarction, Middle Cerebral Artery; Ligusticum; Male; Neuroprotective Agents; Neutrophils; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Pyrazines; Rats; Rats, Wistar; Respiratory Burst; Telencephalon; Tyrosine

2006
Akt inhibits MLK3/JNK3 signaling by inactivating Rac1: a protective mechanism against ischemic brain injury.
    Journal of neurochemistry, 2006, Volume: 98, Issue:6

    Topics: 14-3-3 Proteins; Animals; bcl-2-Associated X Protein; Biological Transport; Brain Ischemia; Caspase 3; Caspases; Cytochromes c; Cytosol; Enzyme Activation; Enzyme Inhibitors; Fas Ligand Protein; Hippocampus; Male; MAP Kinase Kinase Kinases; Membrane Glycoproteins; Mitochondria; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinase Kinase Kinase 11; Neuroprotective Agents; Phosphorylation; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Tumor Necrosis Factor Inhibitors; Tyrosine; Vanadates

2006
Acute ischaemic stroke treated with combined intra-arterial thrombolysis and intravenous tirofiban despite oral anticoagulant therapy at an international normalised ratio > or = 2.0.
    Internal and emergency medicine, 2006, Volume: 1, Issue:3

    Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Brain Ischemia; Contraindications; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Patient Selection; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine

2006
Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia.
    Nuclear medicine and biology, 2006, Volume: 33, Issue:8

    Topics: Animals; Brain Ischemia; Cerebral Cortex; Fluorine Radioisotopes; Male; Methionine; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tritium; Tyrosine

2006
The nitric oxide donor LA 419 decreases ischemic brain damage.
    International journal of molecular medicine, 2007, Volume: 19, Issue:2

    Topics: Animals; Brain Ischemia; Calcium; Disease Models, Animal; Immunohistochemistry; Isosorbide Dinitrate; Magnetic Resonance Imaging; Male; Neurons; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Tyrosine

2007
Deletion of aldose reductase leads to protection against cerebral ischemic injury.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2007, Volume: 27, Issue:8

    Topics: Aldehyde Reductase; Animals; Apoptosis; Behavior, Animal; Brain; Brain Injuries; Brain Ischemia; Caspase 3; Gene Deletion; Imidazolidines; Infarction, Middle Cerebral Artery; Iron; L-Iditol 2-Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Transgenic; Oxidative Stress; Receptors, Transferrin; Transferrin; Tyrosine

2007
Reactive oxygen species plasmatic levels in ischemic stroke.
    Molecular and cellular biochemistry, 2007, Volume: 303, Issue:1-2

    Topics: Aged; Atherosclerosis; Brain Ischemia; Case-Control Studies; Female; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Reactive Oxygen Species; Thrombosis; Tyrosine

2007
Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats.
    Brain research, 2007, Jul-09, Volume: 1157

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Brain Ischemia; Caspase 3; Cerebral Infarction; Chemotaxis, Leukocyte; Cilostazol; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Peroxidase; Poly(ADP-ribose) Polymerases; Probucol; Rats; Rats, Sprague-Dawley; Superoxides; Telencephalon; Tetrazoles; Treatment Outcome; Tyrosine

2007
Age modulates the nitric oxide system response in the ischemic cerebellum.
    Brain research, 2007, Jul-09, Volume: 1157

    Topics: Aging; Animals; Astrocytes; Brain Ischemia; Cerebellar Diseases; Cerebellum; Down-Regulation; Glial Fibrillary Acidic Protein; Gliosis; Isoenzymes; Male; Nerve Tissue Proteins; Neurons; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Reperfusion Injury; Time Factors; Tyrosine; Up-Regulation

2007
PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia.
    Neuroscience letters, 2007, Jun-15, Volume: 420, Issue:3

    Topics: Animals; Blotting, Western; Brain Ischemia; Cell Death; Cell Survival; Disks Large Homolog 4 Protein; Enzyme Inhibitors; Hippocampus; Immunoprecipitation; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Neuroprotective Agents; Phosphorylation; Pyramidal Cells; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; src-Family Kinases; Tyrosine

2007
Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion.
    Neuroscience, 2007, Dec-19, Volume: 150, Issue:4

    Topics: Analysis of Variance; Animals; Apoptosis; Baclofen; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; GABA Agents; In Situ Nick-End Labeling; Male; Muscimol; Neurons; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Reperfusion; src-Family Kinases; Tyrosine

2007
X chromosome-linked inhibitor of apoptosis protein reduces oxidative stress after cerebral irradiation or hypoxia-ischemia through up-regulation of mitochondrial antioxidants.
    The European journal of neuroscience, 2007, Volume: 26, Issue:12

    Topics: Aldehydes; Animals; Antioxidants; Brain; Brain Ischemia; Cytochromes c; Female; Gene Expression; Hypoxia, Brain; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Oxidative Stress; Tyrosine; Up-Regulation; X-Linked Inhibitor of Apoptosis Protein

2007
Tyrosine phosphorylation of HPK1 by activated Src promotes ischemic brain injury in rat hippocampal CA1 region.
    FEBS letters, 2008, Jun-11, Volume: 582, Issue:13

    Topics: Animals; Brain Ischemia; Cytoprotection; Dizocilpine Maleate; Hippocampus; Male; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinase Kinase Kinase 11; Neuroprotective Agents; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; src-Family Kinases; Tyrosine

2008
Regionally selective stimulation of mitogen activated protein (MAP) kinase tyrosine phosphorylation after generalized seizures in the rat brain.
    Neuroscience letters, 1993, Nov-12, Volume: 162, Issue:1-2

    Topics: Animals; Bicuculline; Brain; Brain Ischemia; Dizocilpine Maleate; Enzyme Activation; Hippocampus; Immunoblotting; Mitogens; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Seizures; Somatosensory Cortex; Tyrosine

1993
Tyrosine phosphorylation in a model of ischemia using the rat hippocampal slice: specific, long-term decrease in the tyrosine phosphorylation of the postsynaptic glycoprotein PSD-GP180.
    Journal of neurochemistry, 1995, Volume: 65, Issue:4

    Topics: Animals; Brain Ischemia; Calcium; Hippocampus; In Vitro Techniques; Membrane Glycoproteins; Oxygen; Phosphorylation; Rats; Time Factors; Tyrosine

1995
Inhibition of tyrosine phosphorylation prevents delayed neuronal death following cerebral ischemia.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1993, Volume: 13, Issue:3

    Topics: Animals; Brain Ischemia; Calcium-Calmodulin-Dependent Protein Kinases; Cell Survival; Genistein; Gerbillinae; Hippocampus; Isoflavones; Male; Neurons; Phenols; Phosphorylation; Protein Kinases; Protein-Tyrosine Kinases; Time Factors; Tyrosine

1993
Inhibition of tyrosine phosphorylation attenuates amino acid neurotransmitter release from the ischemic/reperfused rat cerebral cortex.
    Neuroscience letters, 1996, Apr-05, Volume: 207, Issue:3

    Topics: Amino Acids; Animals; Brain Ischemia; Enzyme Inhibitors; Genistein; Isoflavones; Male; Neurotransmitter Agents; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion; Tyrosine

1996
The interactions of nitric oxide with oxygen radicals and scavengers in cerebral ischemic injury.
    Advances in neurology, 1996, Volume: 71

    Topics: Animals; Brain Ischemia; Free Radical Scavengers; Nerve Degeneration; Nitric Oxide; Oxygen; Tyrosine

1996
The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: effect of pretreatment with enadoline (a kappa receptor agonist).
    Brain research, 1996, Mar-18, Volume: 712, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Benzofurans; Blood Glucose; Body Temperature; Brain Ischemia; Cats; Cerebrovascular Circulation; Female; gamma-Aminobutyric Acid; Glutamic Acid; Microdialysis; Pyrrolidines; Receptors, Opioid, kappa; Stereotaxic Techniques; Tyrosine

1996
Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats.
    British journal of pharmacology, 1997, Volume: 121, Issue:3

    Topics: Acetylcholine; Animals; Brain; Brain Ischemia; Choline; Dopamine; Intracranial Embolism and Thrombosis; Male; Neurotransmitter Agents; Pyrrolidinones; Rats; Rats, Wistar; Tryptophan; Tyrosine

1997
Innervation pattern of malformative cortical vessels in Sturge-Weber disease: an histochemical, immunohistochemical, and ultrastructural study.
    Neurosurgery, 1997, Volume: 41, Issue:4

    Topics: Axons; Brain Ischemia; Cerebral Arteries; Cerebral Cortex; Child, Preschool; Female; Humans; Immunohistochemistry; Intracranial Arteriovenous Malformations; Microscopy, Electron; Microscopy, Fluorescence; Nerve Fibers; Neuropeptide Y; Sturge-Weber Syndrome; Synaptic Vesicles; Tyrosine; Tyrosine 3-Monooxygenase

1997
Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Jan-15, Volume: 18, Issue:2

    Topics: Animals; Apoptosis; Brain Ischemia; Cell Line; Cysteine Endopeptidases; Humans; Intracellular Membranes; Lipid Peroxidation; Membrane Lipids; Mice; Mice, Transgenic; Mitochondria; Neurons; Nitrates; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Tyrosine

1998
Dynamics of nitrotyrosine formation and decay in rat brain during focal ischemia-reperfusion.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1999, Volume: 19, Issue:6

    Topics: Animals; Brain Chemistry; Brain Ischemia; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Guanidines; Half-Life; Hydrolysis; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tyrosine

1999
7-Nitroindazole attenuates nitrotyrosine formation in the early phase of cerebral ischemia-reperfusion in mice.
    Neuroscience letters, 1999, Jun-18, Volume: 268, Issue:2

    Topics: Animals; Brain Ischemia; Chromatography, High Pressure Liquid; Indazoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Reperfusion Injury; Tyrosine

1999
Phosphorylation-dependent interaction of the N-methyl-D-aspartate receptor epsilon 2 subunit with phosphatidylinositol 3-kinase.
    Genes to cells : devoted to molecular & cellular mechanisms, 1999, Volume: 4, Issue:11

    Topics: Animals; Binding Sites; Brain Ischemia; Gerbillinae; Mice; Mice, Mutant Strains; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotyrosine; Prosencephalon; Protein Binding; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Rats; Receptors, N-Methyl-D-Aspartate; Synapses; Tyrosine

1999
Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain.
    Journal of neurochemistry, 2000, Volume: 74, Issue:6

    Topics: Animals; Animals, Newborn; Benzamides; Brain Ischemia; Cell Death; Cerebral Infarction; Encephalitis; Female; Male; Motor Activity; Neurologic Examination; Neuroprotective Agents; Neutrophils; Nitrates; Poly(ADP-ribose) Polymerase Inhibitors; Polymers; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Stroke; Time Factors; Tyrosine

2000
Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells.
    Stroke, 2000, Volume: 31, Issue:7

    Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Blood-Brain Barrier; Brain; Brain Ischemia; Caspase Inhibitors; Cattle; Cells, Cultured; Chelating Agents; Cysteine Proteinase Inhibitors; Cytochrome c Group; DNA Fragmentation; Endothelium, Vascular; Free Radicals; Gene Expression Regulation, Enzymologic; Glucose; In Situ Nick-End Labeling; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroarginine; Oxygen; RNA, Messenger; Sorbitol; Spin Labels; Thiocarbamates; Tyrosine

2000
Beneficial effects of n-acetylcysteine on ischaemic brain injury.
    British journal of pharmacology, 2000, Volume: 130, Issue:6

    Topics: Acetylcysteine; Animals; Brain; Brain Edema; Brain Ischemia; Free Radical Scavengers; Gerbillinae; Male; Malondialdehyde; Motor Activity; Nitric Oxide; Peroxidase; Poly(ADP-ribose) Polymerases; Reperfusion Injury; Time Factors; Tyrosine

2000
Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Sep-26, Volume: 97, Issue:20

    Topics: Animals; Brain Ischemia; Calcium-Calmodulin-Dependent Protein Kinases; Cell Death; Glycogen Synthase Kinase 3; Glycogen Synthase Kinases; Humans; Neurons; PC12 Cells; Phosphorylation; Rats; Signal Transduction; Tyrosine

2000
Protective effects of melatonin in ischemic brain injury.
    Journal of pineal research, 2000, Volume: 29, Issue:4

    Topics: Animals; Brain; Brain Edema; Brain Ischemia; Enzyme-Linked Immunosorbent Assay; Free Radical Scavengers; Gerbillinae; Immunoenzyme Techniques; Male; Malondialdehyde; Melatonin; Motor Activity; Nitrates; Nitrites; Oxidative Stress; Peroxidase; Poly(ADP-ribose) Polymerases; Reperfusion Injury; Tyrosine

2000
N-methyl-D-aspartate receptor antagonist reduces nitrotyrosine formation in caudate-putamen in rat focal cerebral ischemia-reperfusion.
    Neuroscience letters, 2001, Feb-16, Volume: 299, Issue:1-2

    Topics: Animals; Brain Ischemia; Calcium Channels; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Neostriatum; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Tyrosine

2001
Hypoxia-ischemia in fetal rabbit brain increases reactive nitrogen species production: quantitative estimation of nitrotyrosine.
    Free radical biology & medicine, 2001, May-01, Volume: 30, Issue:9

    Topics: Animals; Brain Injuries; Brain Ischemia; Female; Fetal Hypoxia; Fetus; Free Radicals; Hypoxia, Brain; Placental Insufficiency; Pregnancy; Rabbits; Reperfusion Injury; Tyrosine

2001
NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusion.
    Brain research, 2001, Aug-03, Volume: 909, Issue:1-2

    Topics: Animals; Brain Ischemia; Excitatory Amino Acid Antagonists; Focal Adhesion Kinase 2; Hippocampus; Immunohistochemistry; Ketamine; Male; Neurons; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; src-Family Kinases; Tyrosine

2001
Immunohistochemical detection of inducible nitric oxide synthase, nitrotyrosine and manganese superoxide dismutase following hyperglycemic focal cerebral ischemia.
    Brain research, 2001, Nov-09, Volume: 918, Issue:1-2

    Topics: Animals; Blood Vessels; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Animal; Hyperglycemia; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Nerve Degeneration; Neuroglia; Neurons; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tyrosine

2001
Dehydroepiandrosterone inhibits the death of immunostimulated rat C6 glioma cells deprived of glucose.
    Brain research, 2001, Dec-20, Volume: 922, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Astrocytes; Brain; Brain Ischemia; Cell Death; Cytokines; Dehydroepiandrosterone; Enzyme Inhibitors; Free Radical Scavengers; Glioma; Glucose; Herbicides; Humans; Interferon-gamma; Lipopolysaccharides; Metalloporphyrins; Molsidomine; Neurons; Nitric Oxide; Oxidative Stress; Paraquat; Peroxynitrous Acid; Superoxide Dismutase; Tumor Cells, Cultured; Tyrosine

2001
Effects of oxygen and glucose deprivation on the expression and distribution of neuronal and inducible nitric oxide synthases and on protein nitration in rat cerebral cortex.
    The Journal of comparative neurology, 2002, Feb-04, Volume: 443, Issue:2

    Topics: Animals; Blotting, Western; Brain Ischemia; Calcium; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Gene Expression; Glucose; Hypoxia; Immunohistochemistry; Magnetic Resonance Imaging; Male; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peroxynitrous Acid; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine

2002
[Effect of ischemia/reperfusion on the phosphorylation of synaptosomal tyrosine of hippocampus of Mongolian gerbils].
    Sheng li xue bao : [Acta physiologica Sinica], 2000, Volume: 52, Issue:2

    Topics: Animals; Brain Ischemia; Calcium Channels, L-Type; Gerbillinae; Hippocampus; Ketamine; Nifedipine; Phosphorylation; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Synaptosomes; Tyrosine

2000
Positron emission tomographical studies of 1-11C-acetoacetate, 2-18F-fluoro-deoxy-D-glucose, and L-1-11C-tyrosine uptake by cat brain with an experimental lesion.
    Acta neurochirurgica, 1989, Volume: 99, Issue:3-4

    Topics: Acetoacetates; Animals; Blood Glucose; Blood-Brain Barrier; Brain; Brain Edema; Brain Injuries; Brain Ischemia; Carbon Radioisotopes; Cats; Cerebrovascular Circulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Freezing; Nerve Tissue Proteins; Parietal Lobe; Tomography, Emission-Computed; Tyrosine

1989